Urine Test Accuracy of Lipoarabinomannan in Diagnosing Pulmonary Tuberculosis in Adults: Meta-Analysis
DOI:
https://doi.org/10.26911/jepublichealth.2022.07.01.04Abstract
Background: Mycobacterium tuberculosis (Mt) requires non-sputum-based screening that can identify it with high sensitivity and specificity. Lipoarabinomannan (LAM) is a diagnosis of active tuberculosis (TB) in samples such as urine, both by complex laboratory-based testing and in simple treatment tools. The purpose of this study was to determine the accuracy of the Lipoarabinomannan urine test in diagnosing TB in adults.
Subjects and Method: This study is a meta-analysis study with PICO covering, population= adult age with suspected tuberculosis (TB). Intervention= lipoarabinomannan urine test. Comparison: no lipoarabinomannan urine test was performed. Outcome: sensitivity and specificity. Using the PRISMA flowchart guidelines. The articles used were conducted between 2012-2021 from the PubMed, Google Scholar, MedLine, and Science Direct databases. The keywords used in the article search were “Lipoarabinomannan” AND “LAM” OR “Adult” AND “Patient” OR “Diagnosis” OR “Pulmonary tuberculosis”. Based on the database, there were 9 articles that matched the inclusion criteria. Data analysis using the RevMan 5.3 application.
Results: A total of 9 cohort studies with a total of 3,069 patients from South Africa (Cape Town, KwaZulu-Natal, Zimbabwe), East Africa (Kenya, Malawi, Tanzania, Uganda, Zambia), West Africa (Ghana) and South America (Peru) were selected for the study. systematic review and meta-analysis. A meta-analysis of 9 cohort studies showed that the lipoarabinomannan urine test had 2.89 times the accuracy or sensitivity in diagnosing TB compared to no lipoarabinomannan urine test (aOR= 2.89; 95% CI= 2.30 to 3.63; p= 0.160), but was not statistically significant.
Conclusion: The lipoarabinomannan urine test improves accuracy in diagnosing pulmonary tuberculosis in adults but is not statistically significant.
Keywords: lipoarabinomannan, LAM, adult, patient, diagnosis, pulmonary tuberculosis.
Correspondence: Jihan Nafisah Fauziy. Masters Program in Public Health. Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Central Java, Indonesia. Email: jihannafisah321@gmail.com. Mobile: 082135798209.
References
Agha MA, El-Helbawy RH, El-Helbawy NG, El-Sheak NM (2013). Utility of quantitative analysis of urine lipoarabinomannan in the diagnosis of tuberculosis. Egypt J Chest Dis Tuberc. 62(3): 401–407. doi: 10.1016/j.ejcdt.2013.06.007.
Balcha TT, Winqvist N, Sturegard E, Skogmar S, Reepalu A, Jemal ZH, Tibesso G, et al. (2014). Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres. TM & IH. 19(6): 734–742. doi: 10.1111/tmi.12308.
Bjerrum S, Broger T, Székely R, Mitarai S, Opintan JA, Kenu E, Lartey M, et al (2020). Diagnostic accuracy of a novel and rapid lipoarabinomannan test for diagnosing tuberculosis among people with human immunodeficiency virus. Open Forum Infec. Dis. 7(1). doi: 10.1093/ofid/ofz530.
Broger T, Sossen B, du Toit E, Kerkhoff AD, Schutz C, Reipold EI, Ward A, et al. (2019). Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study. Lancet Infec. Dis. 19(8): 852–861. doi: 10.1016/S1473-3099-(19)30001-5.
Correia-Neves M, Froberg G, Korshun L, Viegas S, Vaz P, Ramanlal N, Bruch-feld J, et al. (2019). Biomarkers for tuberculosis: The case for lipoarabinomannan. ERJ Open Res. 5(1): 1-13. doi: 10.1183/23120541.00115-2018.
CASP (2018). Critical appraisal skills program cohort study checklist. Retrieved from https://casp-uk.net/-wpcontent/uploads/2018/01/CASP-Cohort-Study-Checklist_2018.pdf.
d’Elia A, Evans D, McNamara L, Berhanu R, Sanne I, Lonnermark E (2015). Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa. Pan Afr Med J. 22: 1–7. doi: 10.11604/pamj.2015.22.4.6075.
Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Walensky RP, et al. (2014). Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: A prospective, clinic-based study. BMC Infect. Dis. 14(1): 1–9. doi: 10.1186/14712334-14-110.
Drain PK, Losina E, Coleman SM, Giddy J, Ross D, Katz JN, Bassett IV (2015). Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis, J. Acquir. Immune Defic. Syndr. 68(3): 274-280. doi: 10.1097/QAI.0000000000000436.
Gupta-Wright A, Corbet EL, Wilson D, vanOosterhout JJ, Dheda K, Huerga H, Peter J, et al. (2019). Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study. PLoS Medicine. 16(4): 1-20. doi: 10.1371/journal.pmed.1002776.
Elhalawany N, Shalaby N, Fathy A, Elmorsy AS, Zaghloul M, El-shahawy H, Hewidy AA (2021). Role of detection of lipoarabinomannan (LAM) in urine for diagnosis of pulmonary tuberculosis in HIV patients: Egyptian experience. Egypt. J Bronchol. 15(1). doi: 10.1186/s43168-021-00067-w.
Flores J, Cancino JC, Chavez-Galan L (2021). Lipoarabinomannan as a Point-of-Care Assay for Diagnosis of Tuberculosis: How Far Are We to Use It?. Front. Microbiol. 12(April). doi: 10.3389/fmicb.2021.638047.
Huerga H, Feriazzo G, Bavilacqua P, Kirubi B, Ardizzoni E, Wanjala S, Sitienel J, et al. (2017). Incremental yield of including determine-TB LAM assay in diagnostic algorithms for hospitalized and ambulatory HIV-positive patients in Kenya. PLoS ONE. 12(1): 1-15. doi: 10.1371/journal.pone.0170976.
Huerga H, Rucker SCM, Bastard M, Mpu-nga J, Quiles IA, Kabaghe C, Sannino L, et al. (2021). Urine Lipoarabino-mannan Testing for All HIV Patients Hospitalized in Medical Wards Identifies a Large Proportion of Patients with Tuberculosis at Risk of Death, Open Forum Infect. Dis. 8(2). doi: 10.1093/ofid/ofaa639.
Izudi J, Tamwesigire IK, Bajunirwe F (2019). Does completion of sputum smear monitoring have an effect on treatment success and cure rate among adult tuberculosis patients in rural Eastern Uganda? A propensity score-matched analysis. PLoS ONE. 14(12): 1-13. doi: 10.1371/journal.pone.0226919.
Jakhar S, Bitzer AA, Stromberg LR, Mu-kundan H, et al. (2020). Pediatric tuberculosis: The impact of “omics” on diagnostics development, Int. J. Mol. Sci. 21(19): 1-19. doi: 10.3390/ijms21196979.
Kerkhoff AD, Wood R, Vogt M, Lawn SD (2014). Predictive value of anemia for tuberculosis in HIV-infected patients in sub-saharan africa: An indication for routine microbiological investigation using new rapid assays, J. Acquir. Immune Defic. Syndr. 66(1): 33-40. doi: 10.1097/QAI.0000000000000091.
Lawn SD, Kerkhoff AD, Burton R, Schutz C, Boulle A, Vogt M, Gupta-Wright A, et al. (2017). Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: A prospective cohort. BMC Med. 15(1): 1-6. doi: 10.1186/s12916-017-0822-8.
Manabe YC, Nonyane BAS, Nakiyingi L, Mbabazi O, Lubega G, Shah M, Moul-ton LH, et al. (2014). Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda. PLoS ONE. 9(7): 11-14. doi: 10.1371/journal.pone.0101459.
Nakiyingi L, Moodley VM, Manabe YC, Nicol MP, Holshouser M, Armstrong DT, Zemanay W, et al. (2014). Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults, J. Acquir. Immune Defic. Syndr. 66(3): 270-279. doi: 10.1097/QAI.0000000000000151.
Nkereuwem E, Togun T, Gomez MP, Sze-kely R, Mace A, Jobe D, Schumacher SG, et al (2021). Comparing accuracy of lipoarabinomannan urine tests for diagnosis of pulmonary tuberculosis in children from four African countries: a cross-sectional study. Lancet Infec. Dis. 21(3): 376-384. doi: 10.1016/S1473-3099(20)30598-3.
Paris L, Magni R, Zaidi F, Araujo R, Saini N, Harpole M, Coronel J, et al. (2017). Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity, Sci. Transl. Med. 9(420): 1-12. doi: 10.1126/sci-translated.aal2807.
Shah M, Ssengooba W, Armstrong D, Nakiyingi L, Holshouser M, Ellner JJ, Joloba M, et al. (2014). Comparative performance of urinary lipoarabino-mannan assays and Xpert MTB/RIF in HIV-infected individuals. LWW. 28(9): 1307-1314. doi: 10.1097/QAD.0000000000000264.
Siswosudarmo R (2017). Tes diagnostik (Diagnostic test)’, Jurnal Metodologi Penelitian. Retrieved from: http://obginugm.com/wp-content/up-loads/2017/09/HRS-Kuliah-Tes-Di-agnostik.pdf.
Sossen B, Ryan A, Bielawski J, Greyling R, Matthews G, Hurribunce-James S, Goliath R, et al. (2021). Urine lipoarabinomannan for rapid tuberculosis diagnosis in HIV-infected adult outpatients in Khayelitsha. S Afr J HIV Med. 22(1): 1–7. doi: 10.4102/sajhivmed. v22i1.1226.
de Vasconcellos K, Ramjathan P, Singh D (2021). The utility of point-of-care urinary lipoarabinomannan testing for the diagnosis of tuberculosis in critically ill patients: a prospective observational study. BMC Infec. Dis. 21(1): 1–14. doi: 10.1186/s12879-021-05979-y.
Zijenah LS, Kadzirange G, Bandason T, Chi-piti MM, Gwambima FM, Chungu P, Kaguru P, et al. (2016). Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Hara-re, Zimbabwe. BMC Infec. Dis, 16(1): 1–9. doi: 10.1186/s12879-016-1339-z.
